* agilon health inc AGL.N reported a quarterly adjusted
loss
of 14 cents per share for the quarter ended in December. The
mean expectation of thirteen analysts for the quarter was for a
loss of 9 cents per share.
* Revenue rose 49% to $689.77 million from a year ago;
analysts
expected $664.36 million.
* agilon health inc's reported EPS for the quarter was a
loss
of 14 cents.
* The mean earnings estimate of analysts had risen by
about 3.4%
in the last three months.
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company.
* agilon health inc shares had risen by 31.4% this quarter.
* The company reported a quarterly loss of $56.47 million.
* Wall Street's median 12-month price target for agilon
health inc
is $26.50
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 14 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
This summary was machine generated from Refinitiv data March 1
at 10:03 p.m. All figures in US dollars unless otherwise
stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Dec. 31 2022 -0.09 -0.14 Missed
Sep. 30 2022 -0.05 -0.07 Missed
Jun. 30 2022 -0.02 -0.05 Missed
Mar. 31 2022 0.00 0.00 Met